Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...

There were empty seats in San Francisco last week at an annual international science conference which has delivered some of the world's most groundbreaking HIV research. It was a throwback to another ...

Also, it doesn’t protect you against sexually transmitted infections, including HIV ... Morning-After Pills Safe? The Plan B One-Step pill and emergency contraception in general are considered ...

Samkelo was barely in his thirties. He did not want to die. The medications he’d been taking since last September had started giving him strength again and, with it, hope. There was a certain haunted ...

Trump's new tariffs on Canada, Mexico, and China take effect, sparking retaliation and raising concerns over trade tensions.

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

A new study by UCSF researchers reveals that long-acting injectable treatments offer a promising alternative for HIV patients who find it challenging to adhere to daily pill regimens. This ...

Patients who struggle to take daily HIV pills can benefit from long-acting ... the UCSF HIV/AIDS clinic at Zuckerberg San Francisco General Hospital. They studied data from 370 patients ...